IL-6 was a logical target to test. It did seem promising.
But the IL-6 story for CVD is now looking a lot like HDL. It seems to be a marker; not a direct cause.
What is it a marker for?
I would argue: A more general pattern of inflammation in arteries and elsewhere.
Inflammation is much more complicated than just IL-6 alone.
The overall inflammatory pattern is what really matters. That’s what is likely causal in CVD. Not this one specific cytokine.
Interventions like diet and colchicine address this whole inflammatory pattern, not just IL-6 by itself. That’s probably why they work, while just inhibiting IL-6 fails.


